Stability of Blood Biomarkers of Traumatic Brain Injury.
暂无分享,去创建一个
M. Wintermark | Y. Li | P. Rezaii | R. Hayes | G. Steinberg | M. Zeineh | G. Grant | B. Jiang | A. Weber | A. Paulino | A. Bet | Kara Richardson | Maria L. Coburn | Kristine Ubungen | Gay Routh | Alex Wheatcroft
[1] J. Ornato,et al. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study , 2018, The Lancet Neurology.
[2] G. Manley,et al. The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis , 2018, Brain injury.
[3] G. Iverson,et al. A Systematic Review of the Usefulness of Glial Fibrillary Acidic Protein for Predicting Acute Intracranial Lesions following Head Trauma , 2017, Frontiers in Neurology.
[4] E. Steyerberg,et al. Blood-Based Protein Biomarkers for the Management of Traumatic Brain Injuries in Adults Presenting to Emergency Departments with Mild Brain Injury: A Living Systematic Review and Meta-Analysis , 2017, Journal of neurotrauma.
[5] D. Menon,et al. Serial Sampling of Serum Protein Biomarkers for Monitoring Human Traumatic Brain Injury Dynamics: A Systematic Review , 2017, Front. Neurol..
[6] J. Bazarian,et al. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury , 2017, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.
[7] L. Papa,et al. Modeling the Kinetics of Serum Glial Fibrillary Acidic Protein, Ubiquitin Carboxyl-Terminal Hydrolase-L1, and S100B Concentrations in Patients with Traumatic Brain Injury. , 2017, Journal of neurotrauma.
[8] J. Henley,et al. Ubiquitin C-terminal hydrolase L1 (UCH-L1): structure, distribution and roles in brain function and dysfunction , 2016, The Biochemical journal.
[9] G. Brophy,et al. Time Course and Diagnostic Accuracy of Glial and Neuronal Blood Biomarkers GFAP and UCH-L1 in a Large Cohort of Trauma Patients With and Without Mild Traumatic Brain Injury. , 2016, JAMA neurology.
[10] F. Tortella,et al. Ability of Serum Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and S100B To Differentiate Normal and Abnormal Head Computed Tomography Findings in Patients with Suspected Mild or Moderate Traumatic Brain Injury , 2016, Journal of neurotrauma.
[11] Yuyuan Li,et al. Serum ubiquitin C-terminal hydrolase L1 as a biomarker for traumatic brain injury: a systematic review and meta-analysis. , 2015, The American journal of emergency medicine.
[12] A. Vafaee,et al. S100B protein as a screening tool for computed tomography findings after mild traumatic brain injury: Systematic review and meta-analysis , 2015, Brain injury.
[13] Hester F. Lingsma,et al. Measurement of the glial fibrillary acidic protein and its breakdown products GFAP-BDP biomarker for the detection of traumatic brain injury compared to computed tomography and magnetic resonance imaging. , 2015, Journal of neurotrauma.
[14] C. Robertson,et al. GFAP out-performs S100β in detecting traumatic intracranial lesions on computed tomography in trauma patients with mild traumatic brain injury and those with extracranial lesions. , 2014, Journal of neurotrauma.
[15] Timothy F Cloughesy,et al. The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings. , 2014, Clinical biochemistry.
[16] Meilan K. Han,et al. Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study , 2014, Journal of Translational Medicine.
[17] Hester F. Lingsma,et al. Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein. , 2014, Journal of neurotrauma.
[18] Hester F. Lingsma,et al. GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study. , 2013, Journal of neurotrauma.
[19] F. Légaré,et al. Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis , 2013, BMJ : British Medical Journal.
[20] Joseph J Crisco,et al. Spectrum of acute clinical characteristics of diagnosed concussions in college athletes wearing instrumented helmets: clinical article. , 2012, Journal of neurosurgery.
[21] J. P. McCoy,et al. Effect of anticoagulants on multiplexed measurement of cytokine/chemokines in healthy subjects. , 2012, Cytokine.
[22] P. Middleton. Practical use of the Glasgow Coma Scale; a comprehensive narrative review of GCS methodology. , 2012, Australasian emergency nursing journal : AENJ.
[23] T. Scalea,et al. Use of Serum Biomarkers to Predict Secondary Insults Following Severe Traumatic Brain Injury , 2012, Shock.
[24] F. Tortella,et al. Elevated levels of serum glial fibrillary acidic protein breakdown products in mild and moderate traumatic brain injury are associated with intracranial lesions and neurosurgical intervention. , 2012, Annals of emergency medicine.
[25] F. Tortella,et al. Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention , 2012, The journal of trauma and acute care surgery.
[26] N. Wilczak,et al. GFAP and S100B in the acute phase of mild traumatic brain injury , 2012, Neurology.
[27] A. Gabrielli,et al. Clinical Utility of Serum Levels of Ubiquitin C-terminal Hydrolase as a Biomarker for Severe Traumatic Brain Injury , 2022 .
[28] Florian Kronenberg,et al. Differences between Human Plasma and Serum Metabolite Profiles , 2011, PloS one.
[29] F. Tortella,et al. Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study , 2011, Critical care.
[30] A. Gabrielli,et al. Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids. , 2011, Journal of neurotrauma.
[31] M. Raichle,et al. Detection of blast-related traumatic brain injury in U.S. military personnel. , 2011, The New England journal of medicine.
[32] Jackson Streeter,et al. Blood-based diagnostics of traumatic brain injuries , 2011, Expert review of molecular diagnostics.
[33] R. Hurley,et al. Common data elements in radiologic imaging of traumatic brain injury , 2010, Journal of magnetic resonance imaging : JMRI.
[34] L. Hansson,et al. Secondary insults following traumatic brain injury enhance complement activation in the human brain and release of the tissue damage marker S100B , 2010, Acta Neurochirurgica.
[35] Ian N. M. Day,et al. UCHL1 (PGP 9.5): Neuronal biomarker and ubiquitin system protein , 2010, Progress in Neurobiology.
[36] D. Streiner,et al. Regional Variability in the Use of CT for Patients with Suspected Mild Traumatic Brain Injury , 2009, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[37] E. Leznik,et al. The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. , 2007, Drug news & perspectives.
[38] K. Waterloo,et al. S100B serum level predicts computed tomography findings after minor head injury. , 2007, The Journal of trauma.
[39] Sen-Yung Hsieh,et al. Systematical evaluation of the effects of sample collection procedures on low‐molecular‐weight serum/plasma proteome profiling , 2006, Proteomics.
[40] W. Mutschler,et al. SERUM S-100B CONCENTRATION PROVIDES ADDITIONAL INFORMATION FOT THE INDICATION OF COMPUTED TOMOGRAPHY IN PATIENTS AFTER MINOR HEAD INJURY: A PROSPECTIVE MULTICENTER STUDY , 2006, Shock.
[41] F. Lecky,et al. Rapid elimination of protein S-100B from serum after minor head trauma. , 2006, Journal of neurotrauma.
[42] Ewout W Steyerberg,et al. Prediction of Outcome in Traumatic Brain Injury with Computed Tomographic Characteristics: A Comparison between the Computed Tomographic Classification and Combinations of Computed Tomographic Predictors , 2005, Neurosurgery.
[43] J. Barrett,et al. Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. , 2005, Clinical chemistry.
[44] H. Tammen,et al. Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display , 2005, Proteomics.
[45] Graham B. I. Scott,et al. HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.
[46] Michael Gaetz,et al. The neurophysiology of brain injury , 2004, Clinical Neurophysiology.
[47] M. Zimmermann,et al. Measurements of Serum S-100B Protein: Effects of Storage Time and Temperature on Pre-Analytical Stability , 2003, Clinical chemistry and laboratory medicine.
[48] A. Brawanski,et al. Early S-100B serum level correlates to quality of life in patients after severe head injury , 2002, Brain injury.
[49] C. Alling,et al. Elimination of S100B and renal function after cardiac surgery. , 2000, Journal of cardiothoracic and vascular anesthesia.
[50] H. Xiong,et al. [Pathophysiological alterations in cultured astrocytes exposed to hypoxia/reoxygenation]. , 2000, Sheng li ke xue jin zhan [Progress in physiology].
[51] Li Chen,et al. Evidence for an Interaction between Ubiquitin-Conjugating Enzymes and the 26S Proteasome , 2000, Molecular and Cellular Biology.
[52] C. Price,et al. The Early Fall in Levels of S-100 β in Traumatic Brain Injury , 2000 .
[53] T. Ingebrigtsen, B. Romner, S. Marup-Jensen, M. Do. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study , 2000 .
[54] C. Alling,et al. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. , 1997, Journal of cardiothoracic and vascular anesthesia.
[55] A. Laupacis,et al. Variation in ED use of computed tomography for patients with minor head injury. , 1997, Annals of emergency medicine.
[56] D. Harris,et al. Neurone-specific enolase and Sangtec 100 assays during cardiac surgery: part II - must samples be spun within 30 min? , 1997, Perfusion.
[57] S. Mirvis,et al. Trauma Radiology: Part IV. Imaging of Acute Craniocerebral Trauma , 1994, Journal of intensive care medicine.
[58] J. Vanderhaeghen,et al. An acidic protein isolated from fibrous astrocytes. , 1971, Brain research.
[59] R. Richterich,et al. Der Einfluß der Enteiweißung auf die Resultate von Serum- und Plasma-Analysen , 1967, Klinische Wochenschrift.
[60] S. Beers,et al. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI. , 2012, Journal of neurotrauma.
[61] J. Ziebell,et al. Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury , 2011, Neurotherapeutics.
[62] R. Alday,et al. Sequential computerized tomography changes and related final outcome in severe head injury patients , 2005, Acta Neurochirurgica.
[63] B. Romner,et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. , 2000, Brain injury.
[64] M. Wiesmann,et al. Measurement of glial fibrillary acidic protein in human blood: analytical method and preliminary clinical results. , 1999, Clinical chemistry.